PT Soho Global Health Tbk operates as a healthcare company in Indonesia. More Details
No risks detected for SOHO from our risk checks.
Flawless balance sheet with acceptable track record.
Share Price & News
How has Soho Global Health's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SOHO is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SOHO's weekly volatility has decreased from 15% to 4% over the past year.
7 Day Return
1 Year Return
Return vs Industry: Insufficient data to determine how SOHO performed against the ID Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SOHO performed against the ID Market.
Long-Term Price Volatility Vs. Market
How volatile is Soho Global Health's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Soho Global Health undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SOHO (IDR5250) is trading below our estimate of fair value (IDR78189.3)
Significantly Below Fair Value: SOHO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SOHO is poor value based on its PE Ratio (27.5x) compared to the ID Pharmaceuticals industry average (25x).
PE vs Market: SOHO is poor value based on its PE Ratio (27.5x) compared to the ID market (22.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SOHO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SOHO is overvalued based on its PB Ratio (3x) compared to the ID Pharmaceuticals industry average (2.4x).
How is Soho Global Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Soho Global Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Soho Global Health performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Quality Earnings: SOHO has high quality earnings.
Growing Profit Margin: SOHO's current net profit margins (2.8%) are higher than last year (2.4%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SOHO's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare SOHO's past year earnings growth to its 5-year average.
Earnings vs Industry: SOHO earnings growth over the past year (43.7%) exceeded the Pharmaceuticals industry 9%.
Return on Equity
High ROE: SOHO's Return on Equity (7.8%) is considered low.
How is Soho Global Health's financial position?
Financial Position Analysis
Short Term Liabilities: SOHO's short term assets (IDR3,406.0B) exceed its short term liabilities (IDR1,797.4B).
Long Term Liabilities: SOHO's short term assets (IDR3,406.0B) exceed its long term liabilities (IDR176.7B).
Debt to Equity History and Analysis
Debt Level: SOHO is debt free.
Reducing Debt: SOHO had no debt 5 years ago.
Debt Coverage: SOHO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SOHO has no debt, therefore coverage of interest payments is not a concern.
What is Soho Global Health current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SOHO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SOHO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SOHO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SOHO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SOHO's dividend in 3 years as they are not forecast to pay a notable one for the ID market.
How experienced are the management team and are they aligned to shareholders interests?
Soho Global Health has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: SOHO only recently listed within the past 12 months.
PT Soho Global Health Tbk's company bio, employee growth, exchange listings and data sources
- Name: PT Soho Global Health Tbk
- Ticker: SOHO
- Exchange: IDX
- Founded: NaN
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: Rp6.663t
- Shares outstanding: 1.27b
- Website: https://www.sohoglobalhealth.com
Number of Employees
- PT Soho Global Health Tbk
- JL. Rawa Sumur II Kav BB No. 3
- awasan Industri Pulogadung, Kel. Jatinegara, Kec. Cakung
- Jakarta Timur
- Jakarta Raya
PT Soho Global Health Tbk operates as a healthcare company in Indonesia. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respi...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/10 17:43|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.